Cargando…
OR3-001 – RIP2 kinase is activated in Blau Syndrome and IBD
Autores principales: | Foley, KP, Desai, B, Vossenkämper, A, Reilly, MA, Biancheri, P, Wang, L, Lipshutz, DB, Connor, J, Miller, M, Haile, PA, Casillas, LN, Votta, BJ, Gough, PJ, MacDonald, TT, Wouters, CH, Rosé, CD, Bertin, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952188/ http://dx.doi.org/10.1186/1546-0096-11-S1-A3 |
Ejemplares similares
-
Identification of Blau Syndrome disease signatures
por: Foley, KP, et al.
Publicado: (2011) -
Life after death: RIP1 and RIP3 move beyond necroptosis
por: Berger, SB, et al.
Publicado: (2016) -
Blau Syndrome, the prototypic auto-inflammatory granulomatous disease
por: Wouters, Carine H, et al.
Publicado: (2014) -
OR3-002 – Blau Syndrome cohort study: ocular outcome
por: Rose, CD, et al.
Publicado: (2013) -
Drilling into RIP1 biology: what compounds are in your toolkit?
por: Berger, S B, et al.
Publicado: (2015)